Photocure ASA: Insiders acquire company shares
Photocure ASA announced that Chairman of the Board Dylan Hallerberg and Board Member Neal Shore have purchased company shares. The transactions involve tens of thousands of shares.
Oslo, Norway – Photocure ASA disclosed on August 7, 2026, that its Chairman of the Board, Dylan Hallerberg, acquired 20,658 shares at an average price of NOK 48.48. Board member Neal Shore also purchased 27,675 shares at an average price of NOK 48.70.
These transactions are considered primary insider notifications in accordance with market abuse regulations. Specific details regarding the timing and rationale behind these acquisitions were not provided in the announcement.
Photocure operates as a commercial diagnostic company with a global reach, focusing on advancing cancer diagnostics and treatment. The company's business involves developing and marketing solutions for medical conditions.
Such insider share purchases can be interpreted as a signal of confidence in the company's future performance by its leadership, particularly in the context of market fluctuations.